Algeria’s trachoma programme meets WHO’s public-health elimination criteria
WHO validated Algeria's milestone in April after reviewing a national dossier. Africa CDC welcomed the result as evidence of sustained public-health work.

The World Health Organization validated Algeria's elimination of trachoma as a public health problem on April 23. The government submitted a dossier in December 2025 showing that Algeria met the agency's criteria. Africa CDC welcomed the decision a day later, adding Algeria to the list of African countries whose results WHO has validated.
Trachoma is an infectious eye disease that can lead to lasting damage and blindness. A determination that it is no longer a public health problem means the country's burden has fallen below defined thresholds and that services can manage remaining cases. It is not a claim that the disease can no longer occur.
The milestone followed a sustained national programme rather than a single intervention. WHO describes a combination of eye care, public-health treatment programmes and conditions that reduce repeated infection, including access to water and sanitation. The validation process asks whether those gains can hold and whether people who develop serious complications can reach care.
The regional picture has continued to change. WHO's July reporting also listed Libya and Tunisia among countries validated in 2026. Each country's decision is based on its own data. The cross-border lesson is that regular monitoring and reachable eye services still matter after validation, particularly in regions where people have historically had less access to care.